📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications. (2022)

First Author: Marzolini C

Attributed to: Liverpool COVID-19 Drug Interactions (www.covid19-druginteractions.org) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.2646

PubMed Identifier: 35567754

Publication URI: http://europepmc.org/abstract/MED/35567754

Type: Journal Article/Review

Volume: 112

Parent Publication: Clinical pharmacology and therapeutics

Issue: 6

ISSN: 0009-9236